as on October 25, 2025 at 1:29 am IST
Day's Low
Day's High
2.24%
Downside
0.90%
Upside
52 Week's Low
52 Week's High
14.80%
Downside
152.89%
Upside
Check Cardiff Oncology Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$147.0M
EPS (TTM)
-0.8483
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-53.9M
Revenue (TTM)
545.0K
Profit Margin
0.00%
Return On Equity TTM
-91.93%
Compare market cap, revenue, PE, and other key metrics of Cardiff Oncology Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $147.0M | -84.33% | NA | 0.00% | |
| BUY | $60.9B | 251.51% | -505.15 | -12.96% | |
| NA | $35.7B | NA | NA | -3.89% | |
| BUY | $109.3B | 99.16% | 30.04 | 31.86% | |
| BUY | $62.0B | -0.32% | 14.51 | 31.37% |
The Cardiff Oncology Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Cardiff Oncology Inc investment value today
Current value as on today
₹83,405
Returns
Returns from Cardiff Oncology Inc Stock
Dollar Returns*
₹4,606 (+4.61%)
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Cardiff Oncology Inc. Average target price of $10.07
Get share price movements and forecasts by analysts on Cardiff Oncology Inc.
What analysts predicted
77.86%UPSIDE
Target Price
$10.07
Current Price
$2.23
Analyzed by
10 Analysts
Target
$10.07
Cardiff Oncology Inc target price $10.07, a slight upside of 77.86% compared to current price of $2.23. According to 10 analysts rating.
Search interest for Cardiff Oncology Inc Stock has increased by 79% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:79% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 109.0K → 121.0K (in $), with an average increase of 9.9% per quarter
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.7% return, outperforming this stock by 83.9%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 130.5% return, outperforming this stock by 86.6%
Profit Down
![]()
Netprofit is down for the last 3 quarters, -11.78M → -13.94M (in $), with an average decrease of 8.9% per quarter
Price Dip
![]()
In the last 3 months, CRDF stock has moved down by -43.8%
| Organisation | Cardiff Oncology Inc |
| Headquarters | 11055 Flintkote Avenue, San Diego, CA, United States, 92121 |
| Industry | Health Services |
| CEO | Dr. Mark Erlander Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Tod Smeal Ph.D. | Chief Scientific Officer |
Ms. Elizabeth Anderson | VP of Finance & Administration |
Ms. Brigitte Lindsay | Senior Vice President of Finance |
Mr. Charles Monahan R.Ph. | Senior Vice President of Regulatory Affairs |
Dr. Roger Sidhu M.D. | Chief Medical Officer |
Dr. Mark Erlander Ph.D. | CEO & Director |
Mr. James E. Levine | Chief Financial Officer |
Cardiff Oncology Inc share price today is $2.23 as on at the close of the market. Cardiff Oncology Inc share today touched a day high of $2.25 and a low of $2.18.
Cardiff Oncology Inc share touched a 52 week high of $5.64 on and a 52 week low of $1.9 on . Cardiff Oncology Inc stock price today i.e. is closed at $2.23,which is 60.46% down from its 52 week high and 17.37% up from its 52 week low.
Cardiff Oncology Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Cardiff Oncology Inc (CRDF) shares with as little as ₹87.796 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹877.96 in Cardiff Oncology Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Cardiff Oncology Inc share’s latest price of $2.23 as on October 25, 2025 at 1:29 am IST, you will get 4.4843 shares of Cardiff Oncology Inc. Learn more about
fractional shares .
Cardiff Oncology Inc stock has given -84.33% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?